Skip to content

Clinical trials

Completed Phase 3 Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Phase 3 Status: Completed Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20041
20061
20091
20101
20112
20122
20136
20141
20153
20161
20182
20192
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen12
Kyowa Kirin Co., Ltd.3
AbbVie (prior sponsor, Abbott)2
OPKO IP Holdings II, Inc.2
Pathalys Pharma2
Sanwa Kagaku Kenkyusho Co., Ltd.2
Abbott1
Creighton University1
Guangdong Provincial People's Hospital1
Kenneth R. Phelps, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary30
Renal Insufficiency, Chronic13
Kidney Failure, Chronic9
Hypocalcemia5
Hyperparathyroidism4
Kidney Diseases3
Parathyroid Diseases3
Renal Insufficiency3
Vitamin D Deficiency3
Chronic Kidney Disease-Mineral and Bone Disorder1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.